249 filings
Page 3 of 13
8-K
07mhdw snp9jrheao
17 May 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:30am
8-K
ac8kaj22l2awl2
13 May 21
Molecular Templates, Inc. Reports First Quarter 2021 Financial Results
4:30pm
8-K
vtddv
5 Apr 21
Termination of a Material Definitive Agreement
7:38am
8-K
q0s daf8ewvi
19 Mar 21
Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results
12:00am
8-K
36rk29lelvqg
22 Feb 21
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
4:36pm
8-K
f0ph6v 43i9tzir
17 Feb 21
Other Events
4:14pm
8-K
vub jz0rf
11 Feb 21
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future sales
7:36am
8-K
4m41o
7 Jan 21
Regulation FD Disclosure
8:00am
8-K
ji9 4je0ero3ibi3v3e5
5 Nov 20
Molecular Templates, Inc. Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
4:32pm
8-K
65xze
6 Aug 20
Molecular Templates, Inc. Reports Second Quarter 2020 Financial Results
4:57pm
8-K
0wpin1zy5y
20 Jul 20
Other Events
4:30pm
8-K
p7cg8cipi6obcf48
28 May 20
Submission of Matters to a Vote of Security Holders
5:10pm
8-K
v9e7v
22 May 20
Molecular Templates, Inc. Announces $45 Million Debt Financing from K2 Healthventures
8:20am
8-K
v0n8bmrpojd0yzhs1
11 May 20
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
4:30pm
8-K
44avt8scbvil
12 Mar 20
Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
4:30pm
8-K
5mes1 hw1i12
19 Dec 19
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
5:23pm
8-K
cb7nsii o9
25 Nov 19
Molecular Templates, Inc. Announces Proposed Public Equity Offering
9:01am
8-K
g7q ev55cm
18 Nov 19
Entry into a Material Definitive Agreement
7:09am
8-K
kgglh 50l8d4h3
12 Nov 19
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
5:00pm
8-K
izxyb2fw as47xb3a
24 Sep 19
Regulation FD Disclosure
8:01am